Related Experiment Videos
Vasopressin and blood pressure
1Department of Medicine, Case Western Reserve University, Cleveland, Ohio.
Kidney International. Supplement
|September 1, 1988
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists.
Expert opinion on investigational drugs·2005
Molecular pharmacology and modeling of vasopressin receptors.
Progress in brain research·2002
Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction.
American journal of physiology. Endocrinology and metabolism·2001
Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists.
Expert opinion on investigational drugs·2001
The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists.
Annual review of pharmacology and toxicology·2001
Mediators of the mitogenic action of human V(1) vascular vasopressin receptors.
American journal of physiology. Heart and circulatory physiology·2000
Effect of kidney disease on glucose handling (including genetic defects).
Kidney international. Supplement·2011
Need for better diabetes treatment for improved renal outcome.
Kidney international. Supplement·2011
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.
Kidney international. Supplement·2011
SGLT2 inhibitors: molecular design and potential differences in effect.
Kidney international. Supplement·2011
Glucose handling by the kidney.
Kidney international. Supplement·2011
Bone: from a reservoir of minerals to a regulator of energy metabolism.
Kidney international. Supplement·2011